Hella Kohlhof
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNIC, INC.
Profil
Hella Kohlhof is currently the Chief Scientific Officer at Immunic, Inc. She previously worked as the Director-Projects Development at 4SC AG, Managing Director at Immunic Research GmbH, and Chief Science Officer at Vital Therapies, Inc. Kohlhof earned a doctorate degree from Ludwig-Maximilians-Universität München.
Aktive Positionen von Hella Kohlhof
Unternehmen | Position | Beginn |
---|---|---|
IMMUNIC, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Ehemalige bekannte Positionen von Hella Kohlhof
Unternehmen | Position | Ende |
---|---|---|
Immunic Research GmbH | Vorstandsvorsitzender | - |
4SC AG | Corporate Officer/Principal | - |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Hella Kohlhof
Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
4SC AG | Health Technology |
IMMUNIC, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Immunic Research GmbH |